Influenza in People With Normal and Weakened Immune Systems
NCT00533182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137
Last updated 2022-11-10
Summary
This study will evaluate how the immune system responds to influenza infection and compare how the infection differs in patients with a weakened immune system versus those with a healthy immune system.
Patients at the NIH Clinical Center who are older than 2 years of age and who are diagnosed with influenza A or B may be eligible for this study. Patients with healthy immune systems and weakened immune systems are included.
Participants answer questions about how they are feeling and have a physical examination to evaluate their symptoms. Blood and nasal fluid are collected on the first day and then every other day for a total of 8 days. Nasal fluid is collected by either inserting a small tube in the nose and washing the nose with salt water and collecting the fluid obtained, or by rubbing the inside of the nose with a swab. Physical examinations are repeated on the days that blood and nasal fluid are collected.
Conditions
- Viral Infections
- Respiratory Infections
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Matthew J Memoli, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-03
- Primary Completion
- 2019-12-31
- Completion
- 2022-08-25
Countries
- United States
Study Locations
More Related Trials
-
Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
NCT02511002 ·Status: ENROLLING_BY_INVITATION
-
The Human Mucosal Immune Responses to Influenza Virus (SLVP026)
NCT03023553 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
Flu Infection at UPHS
NCT06807840 ·Status: RECRUITING
-
Influenza Immunity Against Pandemic Respiratory Virus
NCT00138281 ·Status: COMPLETED ·Phase: PHASE4
-
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
NCT04794829 ·Status: RECRUITING
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Heterosubtypic Immune Responses to Influenza in Older People
NCT00798343 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
H9 Priming Study in Healthy Adults
NCT00617331 ·Status: COMPLETED ·Phase: PHASE2
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients
NCT01149382 ·Status: COMPLETED
-
Proteomic Profiling for Influenza
NCT00133588 ·Status: COMPLETED ·Phase: PHASE4
-
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
NCT05518500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Influenza Vaccine Elicited Immune Response in Immunocompromised Patients
NCT06738082 ·Status: COMPLETED
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Proteomic Profiling for Influenza Vaccination - FluMist
NCT00385281 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine
NCT00535665 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
NCT02297542 ·Status: UNKNOWN ·Phase: PHASE4
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
NCT05215327 ·Status: RECRUITING ·Phase: PHASE2
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
NCT03816878 ·Status: COMPLETED ·Phase: PHASE1
-
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)
NCT03020498 ·Status: COMPLETED ·Phase: PHASE4
-
Blood and Plasma Collection For Use in Future Clinical Trials
NCT01136057 ·Status: COMPLETED
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3